NeuroSense Therapeutics Ltd. Current Accrued Expenses And Other Current Liabilities
NeuroSense Therapeutics Ltd. (NRSN) had Current Accrued Expenses And Other Current Liabilities of $614.00 thousand as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2024-04-04
- 2023-12-31: Current Accrued Expenses And Other Current Liabilities $614.00K.
- 2022-12-31: Current Accrued Expenses And Other Current Liabilities $413.00K.
- 2021-12-31: Current Accrued Expenses And Other Current Liabilities $443.00K.
- 2020-12-31: Current Accrued Expenses And Other Current Liabilities $29.00K.
| Period end | Current Accrued Expenses And Other Current Liabilities |
|---|---|
| 2023-12-31 | $614.00K 20-F · filed 2024-04-04 |
| 2022-12-31 | $413.00K 20-F · filed 2024-04-04 |
| 2021-12-31 | $443.00K 20-F · filed 2023-03-22 |
| 2020-12-31 | $29.00K 20-F · filed 2022-04-14 |